{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:38:58Z","timestamp":1791664738954,"version":"4.3.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T00:00:00Z","timestamp":1542672000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001655","name":"German Academic Exchange Service","doi-asserted-by":"crossref","award":["-"],"award-info":[{"award-number":["-"]}],"id":[{"id":"10.13039\/501100001655","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12913-018-3715-4","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T08:28:30Z","timestamp":1542702510000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Delay in diagnosis and treatment among adult multidrug resistant tuberculosis patients in Yangon Regional Tuberculosis Center, Myanmar: a cross-sectional study"],"prefix":"10.1186","volume":"18","author":[{"given":"Ye Minn","family":"Htun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tin Mi Mi","family":"Khaing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaw","family":"Myint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si Thu","family":"Aung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tin Maung","family":"Hlaing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngamphol","family":"Soonthornworasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udomsak","family":"Silachamroon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuthichai","family":"Kasetjaroen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7916-8460","authenticated-orcid":false,"given":"Jaranit","family":"Kaewkungwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,20]]},"reference":[{"key":"3715_CR1","unstructured":"World Health Organization. Definitions and reporting framework for tuberculosis\u20132013 revision 2013; 10\u20133 p."},{"key":"3715_CR2","unstructured":"World Health Organization. Global tuberculosis report. Global tuberculosis report 2017. Geneva: World Health Organization; 2017. Licence: CC BY-NCSA 3.0 IGO: World Health Organization; 2017. p. 249."},{"issue":"3","key":"3715_CR3","doi-asserted-by":"publisher","first-page":"432","DOI":"10.3201\/eid1703.101553","volume":"17","author":"GE Vel\u00e1squez","year":"2011","unstructured":"Vel\u00e1squez GE, Yagui M, Cegielski JP, Asencios L, Bayona J, Bonilla C, et al. Targeted drug-resistance testing strategy for multidrug-resistant tuberculosis detection, Lima, Peru, 2005\u20132008. Emerg Infect Dis. 2011;17(3):432.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"3715_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12879-016-1524-0","volume":"16","author":"RC Harris","year":"2016","unstructured":"Harris RC, Grandjean L, Martin LJ, Miller AJ, Nkang J-EN, Allen V, et al. The effect of early versus late treatment initiation after diagnosis on the outcomes of patients treated for multidrug-resistant tuberculosis: a systematic review. BMC Infect Dis. 2016;16(1):193.","journal-title":"BMC Infect Dis"},{"key":"3715_CR5","volume-title":"Xpert MTB\/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children: policy update","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. Xpert MTB\/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children: policy update. Geneva: World Health Organization; 2013."},{"key":"3715_CR6","unstructured":"World Health Organization. Xpert MTB\/RIF implementation manual. Technical and operational \u2018how-to\u2019: practical considerations. Geneva, Switzerland: WHO; 2014. WHO\/HTM\/TB\/2014. \n                    http:\/\/apps.who.int\/iris\/bitstream\/10665\/112469\/1\/9789241506700_eng.pdf\n                    \n                  ; 2014."},{"key":"3715_CR7","unstructured":"Uplekar M, World Health Organization. The Stop TB Strategy: Building on and enhancing DOTS to meet the TB-related Millennium Development Goals. 2006."},{"key":"3715_CR8","unstructured":"National Tuberculosis Programme. Guidelines for the Management of Drug Resistant Tuberculosis (DR-TB) in Myamar: Department of Public Health, Ministry of Health and sports, National TB Program and WHO country Office (Myanmar); 2017 . 216 p."},{"key":"3715_CR9","unstructured":"National Tuberculosis Programme. National strategic plan for tuberculosis, 2016\u20132020. Nay Pyi Taw, Myanmar: Department of Public Health, Ministry of Health and Sports; 2016. 15\u201320 p."},{"key":"3715_CR10","first-page":"e3547","volume":"62","author":"T Bodmer","year":"2012","unstructured":"Bodmer T, Str\u00f6hle A. Diagnosing pulmonary tuberculosis with the Xpert MTB\/RIF test. J Vis Exp. 2012;62:e3547.","journal-title":"J Vis Exp"},{"issue":"9776","key":"3715_CR11","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/S0140-6736(11)60438-8","volume":"377","author":"CC Boehme","year":"2011","unstructured":"Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB\/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet. 2011;377(9776):1495\u2013505.","journal-title":"Lancet"},{"issue":"7","key":"3715_CR12","doi-asserted-by":"publisher","first-page":"e103328","DOI":"10.1371\/journal.pone.0103328","volume":"9","author":"P Naidoo","year":"2014","unstructured":"Naidoo P, Du Toit E, Dunbar R, Lombard C, Caldwell J, Detjen A, et al. A comparison of multidrug-resistant tuberculosis treatment commencement times in MDRTBPlus line probe assay and Xpert\u00ae MTB\/RIF-based algorithms in a routine operational setting in Cape Town. PLoS One. 2014;9(7):e103328.","journal-title":"PLoS One"},{"key":"3715_CR13","unstructured":"World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB\/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children: policy update: World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland; 2013. 5\u201312 p."},{"issue":"3","key":"3715_CR14","first-page":"238","volume":"10","author":"MC Raviglione","year":"2006","unstructured":"Raviglione MC. The global plan to stop TB, 2006\u20132015. Int J Tuberc Lung Dis. 2006;10(3):238\u20139.","journal-title":"Int J Tuberc Lung Dis"},{"key":"3715_CR15","unstructured":"Department of Health. Guidelines for the Management of Multidrug Resistant Tuberculosis (MDR-TB) in Myanmar: National Tuberculosis Programme, Department of Health, Ministry of Sports and Health, World Health Organization, Country Office for Myanmar; 2013. 27\u20138 p."},{"issue":"3","key":"3715_CR16","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/rr54","volume":"2","author":"A Somoskovi","year":"2001","unstructured":"Somoskovi A, Parsons LM, Salfinger M. The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis. Respir Res. 2001;2(3):164.","journal-title":"Respir Res"},{"key":"3715_CR17","unstructured":"World Health Organization. Framework for the engagement of all health care providers in the management of drug resistant tuberculosis. Geneva: World Health Organization; 2015. p. 19\u201322."},{"issue":"2","key":"3715_CR18","doi-asserted-by":"publisher","first-page":"163","DOI":"10.5588\/ijtld.14.0369","volume":"19","author":"M Loveday","year":"2015","unstructured":"Loveday M, Wallengren K, Brust J, Roberts J, Voce A, Margot B, et al. Community-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa. Int J Tuberc Lung Dis. 2015;19(2):163\u201371.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"9","key":"3715_CR19","first-page":"397","volume":"5","author":"P Madala","year":"2016","unstructured":"Madala P, Jonnalagadda RK, Sastry TVSN, Samyukta R, Hanumanth N, Raju CN. A study to identify the factors responsible for the delay in treatment initiation of MDR\u2013TB cases registered under RNTCP in a district of South India. Int J Scient Res. 2016;5(9):397\u2013401.","journal-title":"Int J Scient Res"},{"issue":"1","key":"3715_CR20","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1471-2334-5-112","volume":"5","author":"S Yimer","year":"2005","unstructured":"Yimer S, Bjune G, Alene G. Diagnostic and treatment delay among pulmonary tuberculosis patients in Ethiopia: a cross sectional study. BMC Infect Dis. 2005;5(1):112.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"3715_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-015-1253-9","volume":"15","author":"M Rifat","year":"2015","unstructured":"Rifat M, Hall J, Oldmeadow C, Husain A, Milton AH. Health system delay in treatment of multidrug resistant tuberculosis patients in Bangladesh. BMC Infect Dis. 2015;15(1):1.","journal-title":"BMC Infect Dis"},{"key":"3715_CR22","unstructured":"National Tuberculosis Programme. Annual Report, 2016: National Tuberculosis Programme, Department of Public Health, the Ministry of Health and Sports, Republic of the Union of Myanmar; 2018. 7\u201336 p."},{"issue":"5","key":"3715_CR23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1093\/heapol\/czm026","volume":"22","author":"F Karim","year":"2007","unstructured":"Karim F, Islam MA, Chowdhury A, Johansson E, Diwan VK. Gender differences in delays in diagnosis and treatment of tuberculosis. Health Policy Plan. 2007;22(5):329\u201334.","journal-title":"Health Policy Plan"},{"key":"3715_CR24","unstructured":"Department of Health. Five Year National Strategic Plan for Tuberculosis Control 2011. 82\u201396 p."},{"key":"3715_CR25","unstructured":"Daniel WW, Cross CL. Biostatistics: a foundation for analysis in the health sciences. Tenth ed. United States of America 2013; 191\u20133 p."},{"issue":"11","key":"3715_CR26","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1111\/tmi.12566","volume":"20","author":"X Zhang","year":"2015","unstructured":"Zhang X, Yin J, Li H, Li S, Walley J, Zou G, et al. Diagnostic and treatment delays of multidrug-resistant tuberculosis before initiating treatment: a cross-sectional study. Tropical Med Int Health. 2015;20(11):1431\u20137.","journal-title":"Tropical Med Int Health"},{"key":"3715_CR27","unstructured":"World Health Organization. Diagnostic and treatment delay in tuberculosis, An in-depth analysis of the health-seeking behaviour of patients and health system response in seven countries of the Eastern Mediterranean Region Regional Office for the Eastern Mediterranean, PO Box 7608, Nasr City, Cairo 11371, Egypt, World Health Organization; 2006. 15 p."},{"key":"3715_CR28","unstructured":"World Health Organization. Multidrug-resistant tuberculosis (MDR-TB) indicators: a minimum set of indicators for the programmatic management of MDR-TB in national tuberculosis control programmes; 2010. 5 p."},{"key":"3715_CR29","unstructured":"World Health Organization. Tuberculosis control in the South-East Asia Region, Annual TB Report, 2016. Indraprastha Estate, Mahatma Gandhi Marg, New Delhi 110 002, India: World Health Organization, Regional Office for South-East Asia; 2016. 2\u201315 p."},{"issue":"6","key":"3715_CR30","doi-asserted-by":"publisher","first-page":"e0129155","DOI":"10.1371\/journal.pone.0129155","volume":"10","author":"ST Hossain","year":"2015","unstructured":"Hossain ST, Isaakidis P, Sagili KD, Islam S, Islam MA, Shewade HD, et al. The multi-drug resistant tuberculosis diagnosis and treatment cascade in Bangladesh. PLoS One. 2015;10(6):e0129155.","journal-title":"PLoS One"},{"issue":"2","key":"3715_CR31","doi-asserted-by":"publisher","first-page":"e57719","DOI":"10.1371\/journal.pone.0057719","volume":"8","author":"P-C Chan","year":"2013","unstructured":"Chan P-C, Huang S-H, Yu M-C, Lee S-W, Huang Y-W, Chien S-T, et al. Effectiveness of a government-organized and hospital-initiated treatment for multidrug-resistant tuberculosis patients-a retrospective cohort study. PLoS One. 2013;8(2):e57719.","journal-title":"PLoS One"},{"issue":"8","key":"3715_CR32","first-page":"838","volume":"10","author":"M Yagui","year":"2006","unstructured":"Yagui M, Perales M, Asencios L, Vergara L, Suarez C, Yale G, et al. Timely diagnosis of MDR-TB under program conditions: is rapid drug susceptibility testing sufficient? Int J Tuberc Lung Dis. 2006;10(8):838\u201343.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"7","key":"3715_CR33","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1136\/thoraxjnl-2011-200018","volume":"67","author":"L Liang","year":"2012","unstructured":"Liang L, Wu Q, Gao L, Hao Y, Liu C, Xie Y, et al. Factors contributing to the high prevalence of multidrug-resistant tuberculosis: a study from China. Thorax. 2012;67(7):632\u20138.","journal-title":"Thorax"},{"key":"3715_CR34","unstructured":"World Health Organization. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. Geneva: World Health Organization; 2014. p. 15\u201361."},{"key":"3715_CR35","unstructured":"World Health Organization. Strategic plan for the prevention and control of multidrug-resistant and extensively drug-resistant tuberculosis in the eastern Mediterranean region (2010\u20132015). World Health Organization. Regional Office for the Eastern Mediterranean; 2010. p. 81."},{"issue":"1","key":"3715_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4102\/phcfm.v8i1.1089","volume":"8","author":"J Maharaj","year":"2016","unstructured":"Maharaj J, Ross A, Maharaj NR, Campbell L. Multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa: an overview of patients' reported knowledge and attitudes. Afr J Prim Health Care Fam Med. 2016;8(1):1\u20136.","journal-title":"Afr J Prim Health Care Fam Med"},{"issue":"6","key":"3715_CR37","doi-asserted-by":"publisher","first-page":"360","DOI":"10.7196\/SAMJ.5361","volume":"102","author":"R Narasimooloo","year":"2012","unstructured":"Narasimooloo R, Ross A. Delay in commencing treatment for MDR TB at a specialised TB treatment Centre in KwaZulu-Natal. S Afr Med J. 2012;102(6):360\u20133.","journal-title":"S Afr Med J"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-018-3715-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12913-018-3715-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-018-3715-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T20:02:44Z","timestamp":1574193764000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-018-3715-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,20]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3715"],"URL":"https:\/\/doi.org\/10.1186\/s12913-018-3715-4","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,20]]},"assertion":[{"value":"31 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was reviewed and approved by the Ethical Committee, Office of Research Services, Faculty of Tropical Medicine, Mahidol University, Thailand (MUTM 2017\u2013030-01) and Institutional Review Board, Defence Services Medical Research Centre (DSMRC), Myanmar (IRB\/2017\/65). Permission to collecting the data was also obtained from National Tuberculosis Program (NTP), Department of Public Health, Ministry of Health and Sports (MOHS), Myanmar (Letter No. 268\/TB). Before commencement of data collection, the purpose of the study was explained and written informed consent was obtained from each study participant. The results were kept confidentially.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"878"}}